Mn Services Vermogensbeheer B.V. Has $23.68 Million Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Mn Services Vermogensbeheer B.V. grew its stake in HCA Healthcare, Inc. (NYSE:HCA) by 1.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 78,900 shares of the company’s stock after acquiring an additional 1,500 shares during the quarter. Mn Services Vermogensbeheer B.V.’s holdings in HCA Healthcare were worth $23,682,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the company. Whipplewood Advisors LLC acquired a new position in shares of HCA Healthcare in the 4th quarter valued at $31,000. Legacy Investment Solutions LLC acquired a new position in HCA Healthcare in the third quarter valued at about $39,000. Activest Wealth Management lifted its holdings in shares of HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock valued at $40,000 after purchasing an additional 125 shares in the last quarter. Capital Performance Advisors LLP acquired a new stake in HCA Healthcare during the 3rd quarter worth approximately $41,000. Finally, Pinnacle Bancorp Inc. boosted its holdings in shares of HCA Healthcare by 50.0% in the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after buying an additional 50 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of the company’s stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares in the company, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 1.60% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on HCA shares. Morgan Stanley reduced their target price on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 17th. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $380.00 price objective on shares of HCA Healthcare in a report on Tuesday, December 17th. Barclays reduced their price target on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a research report on Monday, January 27th. StockNews.com cut shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. Finally, Raymond James cut shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. One analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $385.67.

HCA Healthcare Price Performance

NYSE:HCA opened at $320.55 on Friday. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The firm has a market capitalization of $79.60 billion, a price-to-earnings ratio of 14.59, a P/E/G ratio of 1.10 and a beta of 1.64. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The stock’s 50 day moving average price is $315.11 and its two-hundred day moving average price is $349.91.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the prior year, the company earned $5.90 EPS. On average, analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be issued a dividend of $0.72 per share. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a yield of 0.90%. The ex-dividend date of this dividend is Monday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.